Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
3.570
-0.200 (-5.31%)
At close: Apr 28, 2026, 4:00 PM EDT
3.490
-0.080 (-2.24%)
After-hours: Apr 28, 2026, 4:31 PM EDT
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $3.33 million as of April 28, 2026. Its market cap has increased by 23.35% in one year.
Market Cap
3.33M
Enterprise Value
3.61M
1-Year Change
23.35%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since June 21, 2019, Artelo Biosciences's market cap has decreased from $12.30M to $3.33M, a decrease of -72.92%. That is a compound annual growth rate of -17.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.70M | 8.00% |
| Dec 31, 2025 | 2.50M | -26.47% |
| Dec 31, 2024 | 3.40M | -24.44% |
| Dec 29, 2023 | 4.50M | -45.78% |
| Dec 30, 2022 | 8.30M | -62.27% |
| Dec 31, 2021 | 22.00M | 100.00% |
| Dec 31, 2020 | 11.00M | 18.28% |
| Dec 31, 2019 | 9.30M | -24.39% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revelation Biosciences | 4.35M |
| 60 Degrees Pharmaceuticals | 4.30M |
| VivoSim Labs | 4.23M |
| Alzamend Neuro | 4.22M |
| AIM ImmunoTech | 4.21M |
| Galmed Pharmaceuticals | 4.13M |
| Matinas BioPharma Holdings | 3.91M |
| Ensysce Biosciences | 3.84M |